Mexico IVD Market Analysis

 
   Single User - $3,500
   Site License (one location, 10 users) - $5,250
   Corporate License - $7,000


Published Jul 25, 2017 | 74 Pages | Pub ID: KLI15419929

Mexico IVD Market Analysis

The Mexican IVD market is considered moderate in its regulatory process and foreign investment opportunities. The health industry is witnessing strong growth with both imports and its growing medical export segments. Several domestic participants have acknowledged the participation in Mexico as a requirement for being a truly global business.

Mexico IVD Market Analysis is designed to provide the reader with an overview of the Mexican laboratory market and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators and controls of the following sub-segments:
  • Clinical Chemistry
  • Immunoassays
  • Microbiology and Molecular Testing
  • Point-of-Care Testing
The Mexican health sector is a mix of both private and public structures, with the private sector responsible for much of the laboratory business. The burden of obesity, diabetes and cardiovascular disease are among the factors that have contributed to the current and future Mexico IVD market outlook as outlined in the report:
  • Mexico IVD Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other, Histology, Other, Total)
  • Mexico In Vitro Diagnostic Sales by Market Segment, 2016, Market Distribution (%) (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other, Histology, Other)
  • Mexico Clinical Chemistry Market, 2016-2021
  • Mexico Immunoassay Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
  • Mexico Microbiology/Molecular Testing Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
  • Mexico Point-of-Care (POC) Market Value by Segment, 2016 vs. 2021 (POC Glucose, POC Other)
  • Mexico Histology Market, 2016-2021
Mexico IVD Market Analysis notes market drivers, which include an increasing interest in molecular testing technologies and point-of-care glucose testing. Included in the report are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences. The report also discusses market drivers and inhibitors for entering Mexico's medical device market.

In Mexico, the use of distributors is common with few IVD suppliers operating directly in the country. The following global providers have very active Mexican subsidiaries/offices and are profiled in the report:
  • Abbott Laboratories
  • Becton, Dickinson And Company
  • bioMérieux S.A.
  • Danaher
  • DiaSorin S.p.A.
  • LifeScan, Inc.
  • Roche (F. Hoffman-La Roche, Ltd.)
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific
The information in Mexico IVD Market Analysis was gathered using both primary and secondary research methods, including more than 20 interviews completed during the period of April 2017 and July 2017. These interviews were with government officials, medical device regulators, Mexico-based distributors, health care providers and leading market participants. Secondary data included the use of government databases, company literature, medical journals, and reports.
CHAPTER 1: EXECUTIVE SUMMARY
INDUSTRY OVERVIEW
SCOPE AND METHODOLOGY
MEXICO IVD MARKET SUMMARY
Figure 1-1: Mexico In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other, Histology, Other)
CHAPTER 2: MEXICO OVERVIEW
POPULATION
Table 2-1: Total Midyear Population by Broad Age Group: Mexico (million persons), 2010-2050 (0-14, 15-64, 65+, Total Population)
Figure 2-1: Total Midyear Population by Broad Age Group: Mexico (million persons), 2010-2050 (0-14, 15-64, 65+)
Figure 2-2: Total Number of Births in Mexico by Year, 1980-2010 and Forecast 2020-2050
Figure 2-3: Mexico Life Expectancy at Birth in Years, 2010-2050
Population Urbanization
ECONOMY AND HEALTH SPENDING
Figure 2-4: Mexico GDP, GDP (PPP) and Health Spending, 1990-2015
Figure 2-5: Mexico Distribution of Income or Consumption by Quintile, 1990-2014 (Income share held by highest 20%, Income share held by fourth 20%, Income share held by third 20%, Income share held by second 20%, Income share held by lowest 20%)
CHAPTER 3: THE HEALTH SYSTEM IN MEXICO
HEALTH INFRASTRUCTURE
Figure 3-1: Health Expenditures, Public vs. Private, as a % of Total Health Expenditures, 2015
Medical Facilities
Figure 3-2: Distribution of JCI Accredited Facilities by Metropolitan Area (Culiacan, Tijuana, Cancun, Chihuahua, Mexico City)
Figure 3-3: Distribution of JCI Accredited Facilities by Type (%; Hospital Program, Ambulatory Care)
Figure 3-4: Distribution of JCI Accredited Facilities by Length of Time from First Accreditation (Withdrawn/Expired, 5+ Years, 2-5 Years, Less Than 2 Years)
Figure 3-5: Hospital Bed Density per 1,000 Population by Country,2016 Estimates (United States, UnitedKingdom, Singapore, Mexico, Japan, Germany, China, Canada, Brazil, Australia) Physicians and Health Professionals 
Figure 3-6: Physician Density per 1,000 Population by Country, 2016 Estimates (United States, United 
Kingdom, Singapore, Mexico, Japan, Germany, China, Canada, Brazil, Australia) 
Figure 3-7: Nurse/Midwife Density per 1,000 Population by Country, 2016 Estimates (United States,United Kingdom, Singapore, Mexico, Japan, Germany, China, Canada, Brazil, Australia) 
The Mexican Diagnostic Laboratory Environment 
Figure 3-8: Laboratories and Collection Sites in Mexico by Type, 2016 (%; Commercial Laboratories,Collection Sites/Patient Service Centers) 
Figure 3-9: Distribution of Volume, Mexico's Leading Clinical Laboratory Service Providers, 2016 (%) Medical Device Regulation 
Table 3-1: Market Drivers and Inhibitors for Entering Mexico's Medical Device Market Mexico's Growing Medical Tourism Industry 
HEALTH INDICATORS 
General Health 
Disease Profiles in Mexico 
Table 3-2: Top 5 Cancers Affecting Mexican Population (ranked by total number of cases), 2010-2016 
Figure 3-10: Medical Conditions/Diseases Prevalence in Mexico (Tuberculosis, Malaria, HIV, Diabetes,Dengue, Cardiovascular Diseases, Cancer)
CHAPTER 4: IVD MARKETS IN MEXICO 
MEXICO IVD MARKET SUMMARY 
Table 4-1: Mexico In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry,Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other, Histology, Other, Total) 
Figure 4-1: Mexico In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry,
 
Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other, 
Histology, Other) 
Figure 4-2: Mexico In Vitro Diagnostic Sales by Market Segment, 2016 Market Distribution (%) (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC GlucosePOC Other, Histology, Other) 
CLINICAL CHEMISTRY 
Figure 4-3: Mexico - Clinical Chemistry Market, 2016-2021 
IMMUNOASSAY 
Table 4-2: Mexico - Immunoassay Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Immunoassay) 
Figure 4-4: Mexico - Immunoassay Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other) 
MICROBIOLOGY/MOLECULAR 
Table 4-3: Mexico - Microbiology/Molecular Testing Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Microbiology/Molecular Testing) 
Figure 4-5: Mexico Microbiology/Molecular Testing Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other) 
POINT-OF-CARE
Table 4-4: Mexico - POC Market Distribution, 2016-2021 (%) (POC Glucose, POC Other, Total POC)
Figure 4-6: Mexico POC Market Value by Segment, 2016 vs. 2021 (POC Glucose, POC Other)
HISTOLOGY
Figure 4-7: Mexico - Histology Market, 2016-2021
CHAPTER 5: COMPETITIVE ANALYSIS AND PROFILES
COMPETITIVE SUMMARY
Table 5-1: Leading IVD Market Suppliers in Mexico, Market Share Percentage, 2016
Figure 5-1: Leading IVD Market Suppliers in Mexico, 2016 (%)
ABBOTT LABORATORIES
Table 5-2: Abbott Laboratories Company Summary
Company Overview
Company Performance
Product Summary
BECTON, DICKINSON AND COMPANY
Table 5-3: Becton, Dickinson and Company Summary
Company Overview
Company Performance
Product Summary
BIOMÉRIEUX S.A.
Table 5-4: bioMerieux Summary
Company Overview
Company Performance
Product Summary
DANAHER
Table 5-5: Danaher Summary
Company Overview
Company Performance
Product Summary
DIASORIN S.P.A.
Table 5-6: DiaSorin S.p.A. Summary
Company Overview
Company Performance
Product Summary
LIFESCAN, INC
Table 5-7: LifeScan Summary
Company Overview
Company Performance
Product Summary
ROCHE (F. HOFFMAN-LA ROCHE, LTD.)
Table 5-8: Roche Group Summary
Company Overview
Company Performance
Product Summary
SIEMENS HEALTHINEERS
Table 5-9: Siemens Healthineers Company Summary
Company Overview
Company Performance
Product Summary
SYSMEX CORPORATION
Table 5-10: Sysmex Corporation Summary
Company Overview
Company Performance
Product Summary
THERMO FISHER SCIENTIFIC
Table 5-11: Thermo Fisher Summary
Company Overview
Company Performance
Product Summary
APPENDIX: SOURCES OF INFORMATION

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.